Overview

This substantially revised second edition contains new chapters on the role of GPIIb/IIIa blockade during acute coronary syndromes or with fibrinolytic therapy during acute myocardial infarctions, and updated and expanded information on the latest trials of GP IIb/IIIa inhibition during percutaneous coronary intervention. Additional improvements include a new chapter on outcomes with chronic oral GP IIb/IIIa blockade following acute coronary syndromes, discussion of GPIIb/IIIa blockade with other platelet and thrombin inhibitors, and a review of the potential effects beyond inhibition of platelet aggregation. Platelet Glycoprotein IIb/IIIa inhibitors in Cardiovascular Disease, Second Edition offers today's physicians, cardiologists, emergency room doctors, and basic scientists the most complete and authoritative review of the state-of-the-art in glycoprotein Iib/IIIa receptor inhibitor use.

Full Product Details

Author:   A. Michael Lincoff
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2nd ed. 2003
Dimensions:   Width: 17.80cm , Height: 2.60cm , Length: 25.40cm
Weight:   2.530kg
ISBN:  

9781588291851

ISBN 10:   1588291855
Pages:   476
Publication Date:   07 March 2003
Audience:   College/higher education ,  Professional and scholarly ,  Undergraduate ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1 Thrombosis in Acute Coronary Syndromes and Coronary Interventions.- 2 Platelet Adhesion.- 3 Glycoprotein IIb/IIIa in Platelet Aggregation and Acute Arterial Thrombosis.- 4 Glycoprotein IIb/IIIa Antagonists: Development of Abciximab and Pharmacology of Abciximab, Tirofiban, and Eptifibatide.- 5 Abciximab During Percutaneous Coronary Intervention: EPIC, EPILOG, and EPISTENT Trials.- 6 Eptifibatide in Coronary Intervention: The IMPACT and ESPRIT Trials.- 7 Tirofiban in Interventional Cardiology: The RESTORE and TARGET Trials.- 8 Overview of the Glycoprotein IIb/Illa Interventional Trials.- 9 The Use of Abciximab in Therapy-Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot Trial and the CAPTURE Study.- 10 Unstable Angina Trials: PARAGON, PURSUIT, PRISM, PRISM-PLUS, and GUSTO-IV.- 11 Platelet Glycoprotein IIb/IIIa Inhibitors and an Invasive Strategy.- 12 Glycoprotein IIb/IIIa Receptor Blockade in Myocardial Infarction: Adjunctive Therapy to Percutaneous Coronary Interventions.- 13 Glycoprotein IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: Adjunctive Therapy to Fibrinolysis.- 14 Economics of Glycoprotein IIb/IIIa Inhibition.- 15 Platelet Monitoring and Interaction of Glycoprotein IIb/IIIa Antagonists with Other Antiplatelet Agents.- 16 Platelet Glycoprotein IIb/IIIa Antagonists: Their Interaction with Low-Molecular-Weight Heparins and Direct Thrombin Inhibitors.- 17 Oral Agents.- 18 Platelet Glycoprotein IIb/IIIa Inhibitors: Effects Beyond the Platelet.- 19 Cerebrovascular Interventions.- 20 Cerebrovascular Aspects of Glycoprotein IIb/IIIa Receptor Inhibitors.- 21 Evolution of Drug Development in Evidence-Based Medicine: Summary and the Future.

Reviews

...provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials...can be recommended not only to cardiologists but to all clinicians and researchers interested in this field. -Intensive Care Medicine

"""...provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials...can be recommended not only to cardiologists but to all clinicians and researchers interested in this field."" -Intensive Care Medicine"

provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials can be recommended not only to cardiologists but to all clinicians and researchers interested in this field. - Intensive Care Medicine

...provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials...can be recommended not only to cardiologists but to all clinicians and researchers interested in this field. -Intensive Care Medicine

...provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials...can be recommended not only to cardiologists but to all clinicians and researchers interested in this field. -Intensive Care Medicine

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions